Discovery of novel dual STAT3/TrxR1 inhibitors via pharmacophore fusion as potent lead compounds for colorectal cancer.
- DOI
- 10.1016/j.bmcl.2026.130777
- Published
- 2026 Sep 10
- Container
- Bioorganic & medicinal chemistry letters
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.bmcl.2026.130777,
title = {Discovery of novel dual STAT3/TrxR1 inhibitors via pharmacophore fusion as potent lead compounds for colorectal cancer.},
author = {Li Y and Xu R and Xie X and Zhao W and He L and Zheng T and Zhang W and Sun P and Xu J and Chen X},
year = {2026},
journal = {Bioorganic \& medicinal chemistry letters},
doi = {10.1016/j.bmcl.2026.130777},
url = {https://doi.org/10.1016/j.bmcl.2026.130777}
}RIS
TY - JOUR TI - Discovery of novel dual STAT3/TrxR1 inhibitors via pharmacophore fusion as potent lead compounds for colorectal cancer. AU - Li Y AU - Xu R AU - Xie X AU - Zhao W AU - He L AU - Zheng T AU - Zhang W AU - Sun P AU - Xu J AU - Chen X PY - 2026 JO - Bioorganic & medicinal chemistry letters DO - 10.1016/j.bmcl.2026.130777 UR - https://doi.org/10.1016/j.bmcl.2026.130777 ER -
APA
Y, L., R, X., X, X., W, Z., L, H., T, Z., W, Z., P, S., J, X., & X, C. (2026). Discovery of novel dual STAT3/TrxR1 inhibitors via pharmacophore fusion as potent lead compounds for colorectal cancer.. Bioorganic & medicinal chemistry letters. https://doi.org/10.1016/j.bmcl.2026.130777
Source records
- pubmed · retrieved 2026-09-27T12:21:06.251Z